Study of skin immune and support cells in systemic sclerosis
Part of Skin clinical trials.
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 or older.
- You have a diagnosis of systemic sclerosis that meets the ACR/EULAR 2013 criteria.
- You can sign informed consent (agree to join the study after understanding it).
- You have health insurance.
- You do NOT have an “overlap” condition with another connective tissue disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a specific type of immune cell activity (called neutrophil extracellular traps) in the blood of people with systemic sclerosis, other connective tissue diseases, and healthy volunteers. It aims to understand how these cells may be involved in the disease and could lead to better treatments.
This study follows adults with systemic sclerosis who are being seen at a specific hospital and asks for consent to store blood and other samples for future research. It may help researchers better understand the disease and develop better tests or treatments over time.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
This study is looking at how systemic sclerosis (a disease that can cause skin thickening and organ problems) affects muscles. It may help find better ways to care for patients.
This study looks at changes in gut bacteria over time in people with systemic sclerosis (a connective tissue disease). It also compares them with healthy adults to understand what gut bacteria patterns may be linked to this condition.
This trial tests a new cell injection treatment (RY_SW01) for people with systemic sclerosis (a condition causing skin thickening and organ issues). It aims to see if the therapy can improve skin hardening and overall symptoms.
Hear when a new Systemic Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.